INFI News and Press, Infinity Pharmaceuticals Inc. From 07/09/20

Document Security Systems (NYSEMKT: DSS ) +69%  after its target acquisition Company, Impact Biomedical reports positive results of equivir and linebacker for treatment of COVID-19. More news on: Document Security Systems, Inc., Infinity Pharmaceuticals, Inc., Dolphin Entertainment...

– The date and time of the 2020 Annual Meeting remain 8:30 a.m. ET on June 17, 2020 – – To participate in the virtual meeting, stockholders must register by 11:59 ET on June 15, 2020 – Infinity Pharmaceuticals, Inc. (the “Company”) (NAS...

Infinity Pharmaceuticals, Inc. (INFI) Q1 2020 Results Conference Call May 11, 2020 4:30 PM ET Company Participants Jayne Kauffman - Senior Executive Coordinator Adelene Perkins - CEO Larry Bloch - President Conference Call Participants Anupam Rama - JPMorgan Kevin DeGe...

Infinity Pharmaceuticals (NASDAQ: INFI ): Q1 GAAP EPS of -$0.19 beats by $0.02 . Revenue of $0.43M (-79.9% Y/Y) beats by $0.23M . Press Release More news on: Infinity Pharmaceuticals, Inc., Earnings news and commentary, Consumer stocks news, ,

– Fast Track Designation Granted for IPI-549 Plus Opdivo ® in Patients with Advanced Urothelial Cancer – – Infinity Voluntarily Pausing Enrollment on MARIO-275 to Evaluate the Risk/Benefit for Patients – – Completion of Enrollment for MARIO...

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on Monday, May 11, 2020 at 4:30 p.m. ET to review its first quarter 2020 financial results and provide an update on the company. A live webcast of the conference call can be accessed in the Investors/Media section...

Infinity Pharmaceuticals, Inc . (NASDAQ: INFI) today provided an update in response to the COVID-19 pandemic. The company has taken steps to ensure the safety of its patients and employees as well as the continued progress of its clinical programs. “The COVID-19 pandemic has creat...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Thinly traded nano cap Infiniti Pharmaceuticals (NASDAQ: INFI ) jumps  18%  premarket on light volume in reaction to its announcement that the FDA has designated lead candidate IPI-549 for Fast Track review for the treatment of advanced urothelial cancer. More news on: Infinity...

Infinity Pharmaceuticals, Inc . (NASDAQ: INFI) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for IPI-549 in combination with nivolumab (Opdivo ® ) for the treatment of advanced urothelial cancer. Infinity is currently enrolling patie...